Publications 2019
329.
Zürbig P, Siwy J, Mischak H.
Emerging urine-based proteomic biomarkers as valuable tools in the management of chronic kidney disease
Expert Rev Mol Diagn. 2019, 19(10):853-856. Epub 2019 Aug 21.
328.
Valiño-Rivas L, Cuarental L, Agustin M, Husi H, Cannata-Ortiz P, Sanz AB, Mischak H, Ortiz A, Sanchez-Niño MD.
MAGE genes in the kidney: identification of MAGED2 as upregulated during kidney injury and in stressed tubular cells
Nephrol Dial Transplant. 2019, 34(9):1498-1507.
327.
Latosinska A, Siwy J, Mischak H, Frantzi M.
Peptidomics and proteomics based on CE-MS as a robust tool in clinical application: The past, the present, and the future
Electrophoresis. 2019, 40(18-19):2294-2308. Epub 2019 May 14.
326.
Siwy J, Mischak H, Zürbig P.
Proteomics and personalized medicine: a focus on kidney disease
Expert Rev Proteomics. 2019, 16(9):773-782. Epub 2019 Aug 23.
325.
Huang QF, Zhang ZY, Van Keer J, Trenson S, Nkuipou-Kenfack E, Yang WY, Thijs L, Vanhaecke J, Van Aelst LNL, Van Cleemput J, Janssens S, Verhamme P, Mischak H, Staessen JA.
Urinary peptidomic biomarkers of renal function in heart transplant recipients
Nephrol Dial Transplant. 2019, 34(8):1336-1343.
324.
Pelander L, Brunchault V, Buffin-Meyer B, Klein J, Breuil B, Zürbig P, Magalhães P, Mullen W, Elliott J, Syme H, Schanstra JP, Häggström J, Ljungvall I.
Urinary peptidome analyses for the diagnosis of chronic kidney disease in dogs
Vet J. 2019, 249:73-79. Epub 2019 May 27.
323.
Vinel C, Schanstra JP, Boizard F, Péreira O, Auriau J, Dortignac A, Breuil B, Feuillet G, Nkuipou-Kenfack E, Zürbig P, Valet P, Bascands JL, Dray C, Denis C.
Apelin affects the mouse aging urinary peptidome with minimal effects on kidney
Sci Rep. 2019, 9(1):10647.
322.
Frantzi M, Gomez Gomez E, Blanca Pedregosa A, Valero Rosa J, Latosinska A, Culig Z, Merseburger AS, Luque RM, Requena Tapia MJ, Mischak H, Carrasco Valiente J.
CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
Br J Cancer. 2019, 120(12):1120-1128. Epub 2019 May 16.
321.
Belczacka I, Pejchinovski M, Krochmal M, Magalhães P, Frantzi M, Mullen W, Vlahou A, Mischak H, Jankowski V.
Urinary Glycopeptide Analysis for the Investigation of Novel Biomarkers
Proteomics Clin Appl. 2019, 13(3):e1800111. Epub 2018 Oct 18.
320.
Ferreira JP, Verdonschot J, Collier T, Wang P, Pizard A, Bär C, Björkman J, Boccanelli A, Butler J, Clark A, Cleland JG, Delles C, Diez J, Girerd N, González A, Hazebroek M, Huby AC, Jukema W, Latini R, Leenders J, Levy D, Mebazaa A, Mischak H, Pinet F, Rossignol P, Sattar N, Sever P, Staessen JA, Thum T, Vodovar N, Zhang ZY, Heymans S, Zannad F.
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure.
Circ Heart Fail. 2019, 12(5):e005897.
319.
Krochmal M, van Kessel KEM, Zwarthoff EC, Belczacka I, Pejchinovski M, Vlahou A, Mischak H, Frantzi M.
Urinary peptide panel for prognostic assessment of bladder cancer relapse
Sci Rep. 2019, 9(1):7635.
318.
Schanstra JP, Luong TT, Makridakis M, Van Linthout S, Lygirou V, Latosinska A, Alesutan I, Boehme B, Schelski N, Von Lewinski D, Mullen W, Nicklin S, Delles C, Feuillet G, Denis C, Lang F, Pieske B, Bascands JL, Mischak H, Saulnier-Blache JS, Voelkl J, Vlahou A, Klein J.
Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment
JCI Insight. 2019, 4(10):e125638.
317.
Siwy J, Klein T, Rosler M, von Eynatten M.
Urinary Proteomics as a Tool to Identify Kidney Responders to Dipeptidyl Peptidase-4 Inhibition: A Hypothesis-Generating Analysis from the MARLINA-T2D Trial
Proteomics Clin Appl. 2019, 13(2):e1800144. Epub 2019 Jan 28.
316.
Lucas-Herald AK, Zürbig P, Mason A, Kinning E, Brown CE, Mansoorian B, Mullen W, Ahmed SF, Delles C.
Proteomic Evidence of Biological Aging in a Child with a Compound Heterozygous ZMPSTE24 Mutation
Proteomics Clin Appl. 2019, 13(2):e1800135. Epub 2018 Dec 27.
315.
Frantzi M, Latosinska A, Mischak H.
Proteomics in Drug Development: The Dawn of a New Era?
Proteomics Clin Appl. 2019, 13(2):e1800087. Epub 2019 Feb 25.
314.
Frantzi M, Mischak H, Latosinska A.
Clinical Proteomics on the Path Toward Implementation: First Promises Delivered
Proteomics Clin Appl. 2019, 13(2):e1800094.
313.
Mokou M, Klein J, Makridakis M, Bitsika V, Bascands JL, Saulnier-Blache JS, Mullen W, Sacherer M, Zoidakis J, Pieske B, Mischak H, Roubelakis MG, Schanstra JP, Vlahou A.
Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease
EBioMedicine. 2019, 41:91-104. Epub 2019 Feb 28.
312.
Fourdinier O, Schepers E, Metzinger-Le Meuth V, Glorieux G, Liabeuf S, Verbeke F, Vanholder R, Brigant B, Pletinck A, Diouf M, Burtey S, Choukroun G, Massy ZA, Metzinger L; European Uremic Toxin Work Group-EUTox.
Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients
Sci Rep. 2019, 14;9(1):4477.
311.
Magalhães P, Krochmal M, Pejchinovski M, Daina E, Caruso MR, Goea L, Belczacka I, Remuzzi G, Umbhauer M, Drube J, Pape L, Mischak H, Decramer S, Schaefer F, Schanstra JP, Cereghini S, Zürbig P.
Urinary proteome signature of Renal Cysts and Diabetes syndrome in children
Sci Rep. 2019, 9(1):2225.
310.
Weidemann F, Beer M, Kralewski M, Siwy J, Kampmann C.
Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA study
Mol Genet Metab. 2019, 126(2):169-182. Epub 2018 Nov 12.
309.
Duranton F, Laget J, Gayrard N, Saulnier-Blache JS, Lundin U, Schanstra JP, Mischak H, Weinberger KM, Servel MF, Argilés A.
The CKD plasma lipidome varies with disease severity and outcome
J Clin Lipidol. 2019, 13(1):176-185.e8. Epub 2018 Aug 1.
308.
Zürbig P, Mischak H, Menne J, Haller H.
CKD273 Enables Efficient Prediction of Diabetic Nephropathy in Nonalbuminuric Patients
Diabetes Care. 2019, 42(1):e4-e5. Epub 2018 Nov 19.
307.
Frantzi M, Latosinska A, Belczacka I, Mischak H.
Urinary proteomic biomarkers in oncology: ready for implementation?
Expert Rev Proteomics. 2019, 16(1):49-63. Epub 2018 Nov 15.
306.
Kanzelmeyer NK, Zürbig P, Mischak H, Metzger J, Fichtner A, Ruszai KH, Seemann T, Hansen M, Wygoda S, Krupka K, Tönshoff B, Melk A, Pape L.
Urinary proteomics to diagnose chronic active antibody-mediated rejection in pediatric kidney transplantation- a pilot study
Transpl Int. 2019, 32(1):28-37. Epub 2018 Nov 12.
305.
Belczacka I, Latosinska A, Metzger J, Marx D, Vlahou A, Mischak H, Frantzi M.
Proteomics biomarkers for solid tumors: Current status and future prospects
Mass Spectrom Rev. 2019, 38(1):49-78. Epub 2018 Jun 11.